Best for: Muscle injuries, multiple concurrent injuries, systemic inflammation Distribution: Whole-body via bloodstream Dosing frequency: Twice weekly during loading, once weekly maintenance Half-life: 24 to 48 hours Unique benefit: Reaches all injury sites from single injection Human Clinical Evidence Human clinical trials for Tb-500 remain remarkably sparse given its widespread underground use, but more data exists than for Bpc-157
Schulz E, Schumann M, Schneemann M, Dony V, Fromm A, Nagel O, et al
& Venema, R
This amplifies gut-to-brain signaling and increases the brains sensitivity to gastrointestinal sensations ( The bloodbrain barrier around the area postrema, is more porous thus allowing it to act as a chemosensory trigger zone for nausea and vomiting ( Unfortunately, beyond the specific GLP-1 pathways, multi-agonist therapies do not bypass the gastrointestinal adverse events despite broader receptor targeting
The ABCs of what Joe Rogan puts in his body | The Daily Show
